Successful bone-marrow transplantation for reticular dysgenesis

Area of Science:

• Immunology
• Hematology
• Pediatric Medicine

Background:

• Reticular dysgenesis is a rare, severe form of combined immunodeficiency.
• It is characterized by a near-complete absence of lymphoid and myeloid cells.
• Bone marrow transplantation is a potential curative therapy.

Observation:

• A male infant diagnosed with reticular dysgenesis underwent a bone-marrow transplant.
• The donor was his HLA-identical brother.
• The infant developed severe graft-versus-host disease post-transplant.

Findings:

• Treatment with high-dose methylprednisolone effectively managed the graft-versus-host disease.
• The patient achieved full hematological reconstitution.
• The child demonstrated normal cell-mediated and humoral immunity three years post-transplant.

Implications:

• This case represents the first reported survival beyond 17 weeks for a child with reticular dysgenesis.
• Successful bone marrow transplantation, even with complications like GVHD, offers a viable treatment pathway.
• This outcome highlights the potential for long-term recovery and normal immune function in infants with reticular dysgenesis.